Hypolipidemic Activity of Diclofenac with Pioglitazone and Bezafibrate

Hypolipidemic Activity of Diclofenac with Pioglitazone and Bezafibrate

Basics, Concepts, Materials and Methods

Versandkostenfrei!
Versandfertig in 6-10 Tagen
32,99 €
inkl. MwSt.
PAYBACK Punkte
16 °P sammeln!
Excessive amount of lipid-intake may result in hyperlipidemia, which is characterized by an abnormal elevation in one or more of the serum lipids such as total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C) and triglycerides (TG). Hyperlipidemia is considered to be a major risk factor for cardiovascular diseases including atherosclerosis, myocardial infarction, heart attacks, and cerebrovascular diseases. Coronary heart disease (CHD) due to atherosclerosis is the leading cause of mortality in the United States and results in about 500,000 deaths each year. The circulatory system...